Palmetto GBA
Skip
permaLink
CPT codes, descriptions, and other data only are copyright 2008 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Apply.

NOTE: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material that is copyrighted by the American Medical Association. You are forbidden to download the files unless you read, agree to, and abide by the provisions of the copyright statement.

West Virginia Part B Carrier
C-Reactive Protein Testing: Medical Necessity Denials

Denial Reason, Reason/Remark Code(s)
  • CO-50, CO-57, CO-151, N-115 - Medical Necessity: An ICD-9 code(s) was submitted that is not covered under a LCD/NCD
  • CPT code: 86141
Resolution/Resources

Refer to the C-Reactive Protein Testing Local Coverage Determination and Coverage Article on the Palmetto GBA Web site:

High sensitivity C-reactive protein testing (high-sensitivity CRP, CPT code 86141) is not covered by Palmetto GBA.

  • Among claims submitted to Palmetto GBA in November and December 2006, one of the services with a high volume of denials is CPT code 86141. These services are denied with reason code 50 / remark code 115.
  • Palmetto GBA has published a non-coverage policy for high sensitivity C-reactive protein. To locate the full text of this policy, refer to:
  • Current literature does not support the use of high sensitivity CRP for diagnostic purposes
  • Medicare does not cover high sensitivity CRP testing for screening, prevention or risk stratification of cardiovascular disease
  • Standard sensitivity CRP (CPT code 86140) is covered as a diagnostic test for the detection and evaluation of infection, tissue injury and inflammatory disease. The results of these diagnostic tests must show an impact to the patient's care plan.
Advance Beneficiary Notice Information
  • Claim Submission for High Sensitivity CRP: because CPT code 86141 is always non-covered by Palmetto GBA on the basis of not reasonable and medically necessary, we encourage you to provide your patients with an Advance Beneficiary Notice (ABN) prior to performing these tests. ABNs allow patients to make an informed decision about whether to receive a service that is likely to be non-covered on the basis of 'not reasonable and medically necessary.'
  • If you utilize ABNs, they must be issued in advance. Maintain the original in the patient's medical record. Provide the patient with a copy of the signed notice.
  • ABNs must be issued using the standard CMS form. For services provided on or after 3/1/2009, you may use the CMS ABN form developed specifically for clinical laboratory services. For services provided on or after 3/1/2009, you must use the revised CMS ABN if you are providing advance notice to a beneficiary. Access the revised ABN and other background information from the CMS Web site.
  • If you have obtained a valid ABN, submit claims for this service with HCPCS modifier GA. Refer to Palmetto GBA Modifier Lookup tool for information on HCPCS modifier GA. Select 'Browse by Topic' on the left side of the Palmetto GBA Web page.

 

last updated on 12/29/2009
CMS